Accelerate Your CAR-T Development with AmplifyBio

At AmplifyBio, we understand that CAR-T cell therapy holds transformative potential in the fight against cancer. Our state-of-the-art facilities and expert team are dedicated to advancing your CAR-T projects from early discovery through to full-scale manufacturing. With a commitment to quality, innovation, and efficiency, we offer a comprehensive suite of services tailored to meet the unique needs of your program.

Comprehensive CAR-T Therapy Solutions:
From Discovery to Delivery

AmplifyBio offers a comprehensive suite of discovery and manufacturing services designed to accelerate the journey from research to patient care. With a focus on precision and innovation, our expert team and state-of-the-art facilities provide the resources and expertise needed to develop and manufacture high-quality CAR-T therapies. We are committed to supporting your mission to bring life-changing treatments to market, ensuring every step of the process meets the highest standards of quality and efficiency.

Integrated Discovery Solutions

Navigating the complexities of CAR-T discovery requires precision and expertise. At AmplifyBio, we offer robust lead discovery and optimization services designed to help you bring your CAR T cell therapy to market quickly and efficiently. Our integrated approach includes:

End-to-End CAR-T Manufacturing

With our comprehensive manufacturing services, AmplifyBio ensures your CAR-T therapies are produced to the highest standards, from clinical trials to commercial scale. Our offerings include:

Regulatory Expertise

Navigating the regulatory landscape is crucial for successfully developing and commercializing CAR-T therapies. AmplifyBio’s regulatory team provides expert guidance and support throughout your program, ensuring compliance with all relevant guidance and accelerating your time to market.

A Facility Built for Advanced Therapy Manufacturing

Advanced therapies experience 400% more chemistry, manufacturing, and control (CMC) related developmental disruptions when compared to other large molecule biologics such as mAbs. AmplifyBio is addressing that challenge by building manufacturing centers where robust characterization is integrated into a manufacturing strategy, ensuring that not only is process development critical but that also, the PRODUCT is the PRODUCT.

What do we mean by that? Process and analytic development is critical when manufacturing cell and gene therapies, but at AmplifyBio you will also identify the product characteristics that ensure the product at discovery, is the same one being scaled up. 

AMEC Warehouse Storage and Logistics Facility
New Albany, Ohio

Contact Us

Comprehensive service programs for the development of Cell and Gene Therapy (CGT), mRNA, and other advanced therapies from concept to commercial. Offering expertise and support in discovery, characterization, preclinical CRO safety testing, and scalable manufacturing available in an integrated, innovation-rich environment that goes beyond the value proposition offered by traditional CDMO and PDMO contract models.